Clinical Trial Update: Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for the Kagoshima Collaborate Trial in Metabolic Syndrome (KACT) sponsored by Kagoshima University. The trial targets hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Snippet

Sponsor: Kagoshima University | Conditions: Hypertension, Obesity | Phase 4 | Status: UNKNOWN